A German cannabis physician, a nurse and a pharmacist walk into a bar...I mean a podcast. In this fascinating episode of Reefer MEDness, Trevor (pharmacist) and Kirk (registered nurse) sit down with Dr. Vlad Gavril, a German GP specializing in cannabinoid therapy, to explore how medical cannabis is transforming patient care in Germany.

Dr. Vlad explains how Germany’s partial cannabis legalization in April 2024 dramatically changed access to medical cannabis. But with this rapid expansion comes challenges: inconsistent patient education, and stigma around cannabis.

The conversation unpacks how Dr. Vlad uses cannabis clinically—from chronic pain and insomnia to depression and ADHD—and why education about cannabinoids, terpenes, and individualized treatment is critical. Dr. Vlad shares how he guides patients toward vaporization rather than smoking, explores terpene-based strain selection, and explains the importance of activating the body’s endocannabinoid system through lifestyle changes alongside cannabis therapy.

This episode offers rare insight into the rapidly evolving global landscape of medical cannabis policy, patient care, and cannabinoid science.

Listen now to learn how cannabis medicine is being practiced in Germany—and what Canadian clinicians and patients can learn from it.

Can a massive data project finally answer the biggest questions about medical cannabis?

In Part 2 of our conversation with Dr. Johannes Thrul, we explore the National Cannabis Study, an ambitious effort to build a global repository of cannabis research and real-world patient data. From standardized tools like the Cannabis Use Questionnaire to combining datasets from multiple studies, this project aims to uncover how cannabis truly impacts conditions like chronic pain, anxiety, PTSD, and insomnia.

With AI analysis, collaborative research, and a goal of 10,000 participants, the team hopes to transform fragmented cannabis studies into one powerful evidence base.

Listen now to learn how this groundbreaking cannabis database could reshape the future of cannabis medicine.

Johannes Thrul - LinkedIn

Cannabis & Health Research Initiative - website

Transcripts, papers and so much more at: reefermed.ca

What truth can big data unlock about medical cannabis?

Dr. Johannes Thrul from Johns Hopkins talks about cannabis use disorder, psychiatric risks, THC intoxication, and the groundbreaking Cannabis Health Research Initiative.

The ambitious Cannabis Health Research Initiative is a groundbreaking effort to build a national medical cannabis registry and research database. Dr. Thrul shares how the National Cannabis Study will track new medical cannabis users over time, analyze biomarkers and electronic health records, and use AI to identify if medicinal cannabis is helping or not. The goal: generate real-world evidence about the benefits, risks, and clinical applications of cannabinoids—helping researchers design better clinical trials and improve patient care.

Listen now to learn how real-world data may reshape the science of cannabis medicine.

Johannes Thrul - LinkedIn

Cannabis & Health Research Initiative - website

Transcripts, papers and so much more at: reefermed.ca